Efficacy of Kolofort in Combined Functional Gastroenterological Pathology: an Open Study

Efficacy of Kolofort in Combined Functional Gastroenterological Pathology: an Open Study

Aim. The study aims to evaluate the efficacy and safety of Kolofort administration in patients suffering from irritable bowel syndrome (IBS) and functional dyspepsia (FD), as well as the prevalence of somatic and polymorbid psychomental disorders (distress, depression, anxiety and somatisation) in t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. P. Uspenskiy, O. S. Mirzoev, Yu. A. Fominykh, A. A. Gnutov, S. V. Polyushkin
Format:	Article
Language:	Russian
Published:	Gastro LLC 2020-12-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	combined functional digestive disorders functional dyspepsia irritable bowel syndrome distress depression anxiety somatisation “7x7” questionnaire 4dsq kolofort
Online Access:	https://www.gastro-j.ru/jour/article/view/529
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dynamics of Somatic and Comorbid Mental Disorders (Distress, Anxiety, Somatisation and Depression) in Patients with Irritable Bowel Syndrome during Therapy with Alimemazine: Results of an Non-Interventional Observational Programme (“Terra”)
by: V. T. Ivashkin, et al.
Published: (2019-01-01)

Probiotics in the Complex Treatment of Various Diseases of the Gastrointestinal Tract
by: K. V. Ivashkin, et al.
Published: (2020-04-01)

Efficacy of Trimebutine Maleate (Trimedat®) in the Treatment of Patients with Functional Dyspepsia: Results of the “TREND” Observational Study
by: S. S. Kardasheva, et al.
Published: (2018-11-01)

Discussion of irritable bowel syndrome issue and functional constipations in reports of the 21st United European Gastroenterological Week (Berlin, 2013)
by: A. A. Sheptulin, et al.
Published: (2014-09-01)

Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases
by: A. A. Sheptulin
Published: (2022-01-01)

Combination of functional dyspepsia syndrome and irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2011-06-01)

Functional Disorders of the Gastrointestinal Tract During the Pandemic of a New Coronavirus Infection
by: A. A. Sheptulin, et al.
Published: (2022-09-01)

Gastroesophageal reflux disease and the functional diseases of gastro-intestinal tract: are there any interrelations?
by: A. A. Sheptulin, et al.
Published: (2010-08-01)

Discussion of functional dyspepsia issue in American gastroenterological week reports (Orlando, 2013)
by: A. A. Sheptulin
Published: (2014-07-01)

Modern Possibilities of Using Acotiamide in the Treatment of Functional Dyspepsia
by: A. A. Sheptulin, et al.
Published: (2024-03-01)

Excessive Belching: a Separate Syndrome or Another Symptom of Functional Dyspepsia?
by: A. A. Sheptulin, et al.
Published: (2020-07-01)

COVID-19 Pandemic and Irritable Bowel Syndrome — is there a Relationship?
by: V. A. Akhmedov
Published: (2022-08-01)

The Effectiveness of Add-on Treatment with Nutraceutical
by: V. T. Ivashkin, et al.
Published: (2022-08-01)

Experience in the Treatment of Irritable Bowel Syndrome Developed after a New Coronavirus Infection (COVID-19)
by: R. G. Myazin
Published: (2022-05-01)

The Role of Motility Impairment in the Pathogenesis of Functional Disorders of the Gastrointestinal Tract and Modern Possibilities for Their Treatment (Resolution of an Expert Council and Literature Review)
by: I. V. Maev, et al.
Published: (2020-01-01)

Quality of Life and Level of Physical Activity In Students with and without Symptoms of Functional Dyspepsia and Irritable Bowel Syndrome Surveyed with Questionnaire “7×7” (7 Symptoms Per 7 Days)
by: T. V. Zhestkova
Published: (2020-07-01)

Simulated gastrointestinal digestion of milk caseins containing A1 β-casein does not lead to increased production of inflammatory proteins in intestinal epithelial cells in vitro when compared to milk caseins containing A2 β-casein.
by: Alan Aitchison, et al.
Published: (2025-02-01)

COVID-19 Pandemic and IBS. Results of the All-Russian Observational Non-interventional Program to Study the Effectiveness of the Drug Kolofort® in Real Clinical Practice in Patients with Irritable Bowel Syndrome After a New Coronavirus Infection (VESNA)
by: V. T. Ivashkin, et al.
Published: (2023-12-01)

KAB-Newsletter-Issue-7.
by: Sempungu, Godfrey J. (Chief Ed.), et al.
Published: (2024)

Возможности применения Опросника «7х7» (7 симптомов за 7 дней) для оценки динамики симптомов функциональной диспепсии и синдрома раздраженного кишечника
by: V. T. Ivashkin, et al.
Published: (2016-08-01)

Diet in the Management of Functional Dyspepsia: Controversial and Unresolved Issues
by: A. A. Sheptulin, et al.
Published: (2023-09-01)

Efficacy of the herbal preparation STW 5 in multi-target therapy of functional dyspepsia
by: A. A. Sheptulin, et al.
Published: (2015-10-01)

Transcriptome-proteome integration analysis identifies elevated expression of LARP7 promoting the tumorigenesis and development of gastrointestinal stromal tumors
by: Heng Zheng, et al.
Published: (2025-03-01)

Consensus Meeting of European Society of Neurogastroenterology and Motility on Functional Dyspepsia (2020): Have We Dotted All the I’s?
by: A. A. Sheptulin, et al.
Published: (2021-06-01)

Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program)
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Treatment of Functional Dyspepsia in Outpatients after COVID-19 Infection
by: M. S. Turchina, et al.
Published: (2023-05-01)

Chronic gastritis and functional dyspepsia: is there an exit out of the dead spot? (reflections, blown together by Rome criteria III)
by: A. A. Sheptulin
Published: (2010-04-01)

Esophageal lesions at irritable bowel syndrome
by: M. G. Mnatsakanyan, et al.
Published: (2015-10-01)

Role of depression in development of functional dyspepsia symptoms
by: D. B. Kolesnikov, et al.
Published: (2011-06-01)

Practical Recommendations of Scientific Society for the Study of Human Microbiome and the Russian Gastroenterological Association on Use of Probiotics, Prebiotics, Synbiotics and Functional Foods in Treatment and Prevention of Gastroenterological Diseases in Children and Adults
by: V. T. Ivashkin, et al.
Published: (2021-06-01)

Duodenal Eosinophilia in Functional Dyspepsia
by: A. S. Silaeva, et al.
Published: (2023-08-01)

Discussion of the problem of functional constipation and irritable bowel syndrome in the reports of the International Congress on Neurogastroenterology and Motility (Bologna, 2012)
by: A. A. Sheptulin, et al.
Published: (2013-03-01)

Diagnosis of Functional Gastrointestinal Disorders and Choice of Treatment Regimen in Constipation Patients
by: I. V. Maev, et al.
Published: (2021-10-01)

Functional Dyspepsia and Gastroesophageal Reflux Disease: From Pathogenesis to Current Treatment Strategies
by: A. S. Trukhmanov, et al.
Published: (2024-12-01)

Sulfatase modifying factor 2 as a predictive biomarker for urothelial carcinoma
by: Wei-Ting Kuo, et al.
Published: (2025-02-01)

Psychological and autonomous nervous system features of functional gastric dyspepsia and irritable bowel syndrome, duloxetine treatment efficacy
by: A. P. Pogromov, et al.
Published: (2012-06-01)

Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational Therapy
by: S. N. Mekhdiyev, et al.
Published: (2022-12-01)

Intestinal Barrier, Permeability and Nonspecific Inflammation in Functional Gastrointestinal Disorders
by: A. L. Kovaleva, et al.
Published: (2020-09-01)

Present-day pathophysiological concept of functional dyspepsia
by: I. V. Mayev, et al.
Published: (2015-09-01)

Modern approaches to functional dyspepsia treatment
by: A. A. Sheptulin
Published: (2014-12-01)